Spabond 540 Slow Hardener

Hazard statements (CLP)

H314, H317, H318, H361, H373, H412

Code

Statements

H314

Causes severe skin burns and eye damage

SECTION 2: Hazards identification

Adverse physicochemical, human health and environmental effects

Suspected of damaging fertility. Suspected of damaging the unborn child. (if inhaled). May cause damage to organs (liver, skeletal muscle) through prolonged or repeated exposure (if inhaled). Causes severe skin burns and eye damage. May cause an allergic skin reaction. Causes serious eye damage. Harmful to aquatic life with long lasting effects.

2.2 Label elements

Labelling

Hazard pictograms

GHS05 GHS07 GHS08

Signal word

Danger

Contains

2-piperazin-1-ylethylamine; Propylene glycol diamine, 2-amino-, diether with Propylene

Hazard statements

H314 - Causes severe skin burns and eye damage. H317 - May cause an allergic skin reaction. H361 - Suspected of damaging fertility. Suspected of damaging the unborn child. (if inhaled). H373 - May cause damage to organs (respiratory tract) through prolonged or repeated exposure (if inhaled). H412 - Harmful to aquatic life with long lasting effects.

Precautionary statements

P201 - Obtain special instructions before use. P202 - Do not handle until all safety precautions have been read and understood. P260 - Do not breathe vapours. P264 - Wash hands thoroughly after handling. P272 - Contaminated work clothing should not be allowed out of the workplace. P273 - Avoid release to the environment.

2.3 Other hazards

Contains no PBT and/or vPvB substances ≥ 0.1% assessed in accordance with REACH Annex XIII Component Substance(s) not meeting the PBT criteria of REACH 4-tert-butylphenol (98-54-4) regulation, in accordance with Annex XIII Substance(s) not meeting the vPvB criteria of REACH 4-tert-butylphenol (98-54-4) regulation, in accordance with Annex XIII The mixture contains substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 Component Substance(s) included in the list established in 4-tert-butylphenol (98-54-4) accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605